Experienced in Familial Adenomatous Polyposis

Jian Meng

Beijing Key Laboratory Of Preclinical Research And Evaluation For Cardiovascular Implant Materials, State Key Laboratory Of Cardiovascular Disease, Chinese Academy Of Medical Sciences & Peking Union Medical College, 
Beijing, CN 
Experienced in Familial Adenomatous Polyposis
Beijing Key Laboratory Of Preclinical Research And Evaluation For Cardiovascular Implant Materials, State Key Laboratory Of Cardiovascular Disease, Chinese Academy Of Medical Sciences & Peking Union Medical College, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Jian Meng practices in Beijing, China. Mr. Meng is rated as an Experienced expert by MediFind in the treatment of Familial Adenomatous Polyposis. His top areas of expertise are Familial Adenomatous Polyposis, Myocarditis, Heart Tumor, Hypertension, and Heart Transplant.

His clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Familial Adenomatous Polyposis.

Gender
Male

Locations

Beijing Key Laboratory Of Preclinical Research And Evaluation For Cardiovascular Implant Materials, State Key Laboratory Of Cardiovascular Disease, Chinese Academy Of Medical Sciences & Peking Union Medical College, Beijing, 102300, China
Other Locations
Langfang, 065000, China
300000 P.R. China, Tianjin, 300000, China
Xuzhou, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

31 Total Publications

Correction: MiR-7683-3p from M2-exosomes attenuated atherosclerosis by activating the PPARγ-LXRα-ABCG1 pathway mediated cholesterol efflux of vascular smooth muscle cell derived foam cells.
Correction: MiR-7683-3p from M2-exosomes attenuated atherosclerosis by activating the PPARγ-LXRα-ABCG1 pathway mediated cholesterol efflux of vascular smooth muscle cell derived foam cells.
Journal: Journal of nanobiotechnology
Published: November 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Meng's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile